Windtree Therapeutics, a biotechnology company focused on developing aerosolized KL4 surfactant therapies for respiratory diseases, and CVie Investments Limited (CVie), together with its wholly-owned subsidiary, CVie Therapeutics Limited, a privately-held company focused on developing drugs to treat cardiovascular diseases, have entered an agreement for the merger of a Windtree Therapeutics subsidiary and CVie. The combined company, which will retain the name Windtree Therapeutics, will be a ful...